Natus Medical EBITDA Margin Trend

Natus Medical Incorporated -- USA Stock  

USD 28.45  0.3  1.07%

This module enables investors to look at Natus Medical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 42.4 M, Cost of Revenue of 152.7 M or Earning Before Interest and Taxes EBIT of 56.5 M, but also many exotic indicators such as Interest Coverage of 194, Long Term Debt to Equity of 0.1056 or Calculated Tax Rate of 32.5157. This module is a perfect complement to use when analyzing Natus Medical Valuation or Volatility. It can also complement various Natus Medical Technical models. Check also analysis of Natus Medical Correlation with competitors.
Showing smoothed EBITDA Margin of Natus Medical Incorporated with missing and latest data points interpolated. Measures the ratio between a company's Earnings Before Interest Taxes and Depreciation Amortization EBITDA and Revenues.
EBITDA Margin  10 Years Trend  
Increasing
Slightly volatile
 EBITDA Margin 
      Timeline 

Natus Medical EBITDA Margin Over Time

2016-12-31  0.19 
2017-12-31  0.19 
2018-12-31  0.19 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  0.13
Geometric Mean  0.1
Coefficient Of Variation  72.91
Mean Deviation  0.06736
Median  0.16
Standard Deviation  0.09275
Sample Variance  0.008603
Range  0.32
R Value  0.48
Mean Square Error  0.007202
R Squared  0.23
Significance  0.095108
Slope  0.011486
Total Sum of Squares  0.1

Currently Trending

DHR   
 NYQ 
Purchased over 90 shares of
31 mins ago ago
Traded for 99.69
FDRVF   
 PNK 
Purchased few shares of
42 mins ago ago
Traded for 57.85
THCBF   
 PNK 
Purchased over 500 shares of
42 mins ago ago
Traded for 1.62